ZA988527B - Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents. - Google Patents

Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents.

Info

Publication number
ZA988527B
ZA988527B ZA9808527A ZA988527A ZA988527B ZA 988527 B ZA988527 B ZA 988527B ZA 9808527 A ZA9808527 A ZA 9808527A ZA 988527 A ZA988527 A ZA 988527A ZA 988527 B ZA988527 B ZA 988527B
Authority
ZA
South Africa
Prior art keywords
4alkyl
hydrogen
4alkyloxy
halo
optionally substituted
Prior art date
Application number
ZA9808527A
Other languages
English (en)
Inventor
Henricus Johannes Mathe Snoeck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA988527B publication Critical patent/ZA988527B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA9808527A 1997-09-18 1998-09-17 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents. ZA988527B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202862 1997-09-18

Publications (1)

Publication Number Publication Date
ZA988527B true ZA988527B (en) 2000-03-22

Family

ID=8228735

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9808527A ZA988527B (en) 1997-09-18 1998-09-17 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents.

Country Status (8)

Country Link
US (1) US6544979B1 (ja)
EP (1) EP1011726B1 (ja)
JP (1) JP3775780B2 (ja)
AT (1) ATE233104T1 (ja)
AU (1) AU1146099A (ja)
DE (1) DE69811689T2 (ja)
WO (1) WO1999013871A2 (ja)
ZA (1) ZA988527B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586475B1 (en) * 1998-11-20 2003-07-01 Takeda Chemical Industries, Ltd. β-amyloid protein production/secretion inhibitors
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
EP1401838B1 (en) 2001-06-12 2014-03-26 Janssen Pharmaceutica NV Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
DK1451196T3 (da) * 2001-11-23 2007-11-12 Janssen Pharmaceutica Nv Anvendelse af substituerede tetracykliske imidazolderivater som antihistaminstoffer
AU2003226188A1 (en) * 2002-04-10 2003-10-27 Ortho-Mcneil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
WO2014087208A2 (en) * 2012-12-06 2014-06-12 Enaltec Labs Pvt. Ltd. A process of preparing alcaftadine
WO2020146822A1 (en) * 2019-01-11 2020-07-16 Naegis Pharmaceuticals Inc. Leukotriene synthesis inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101850A (en) 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
KR100251295B1 (ko) * 1992-12-04 2000-05-01 디르크 반테 항앨러지성 이미다조[1,2-a](피롤로, 티에노 또는 푸라노)[2,3-d]아제핀 유도체(Antiallergic imidazo[1,2-a](pyrrolo, thieno or furano)[2,3-d]azepine derivatives)
TW382017B (en) * 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
TW527186B (en) * 1996-03-19 2003-04-11 Janssen Pharmaceutica Nv Fused imidazole derivatives as multidrug resistance modulators

Also Published As

Publication number Publication date
EP1011726A2 (en) 2000-06-28
US6544979B1 (en) 2003-04-08
WO1999013871A3 (en) 1999-06-03
EP1011726B1 (en) 2003-02-26
WO1999013871A2 (en) 1999-03-25
DE69811689T2 (de) 2003-12-18
ATE233104T1 (de) 2003-03-15
DE69811689D1 (de) 2003-04-03
JP2001516716A (ja) 2001-10-02
JP3775780B2 (ja) 2006-05-17
AU1146099A (en) 1999-04-05

Similar Documents

Publication Publication Date Title
NO994268D0 (no) Farnesyltransferase-inhiberende 1,8-annelerte kinolinonderivater substituert med N- eller C-bundede imidazoler
MXPA05008364A (es) Derivados de pirimidina para la prevencion de una infeccion por vih.
MXPA04001400A (es) Derivados de tiazolilo 2,4,5-tri-substituidos y su actividad anti-inflamatoria.
CA2288140A1 (en) Farnesyltransferase inhibiting quinazolinones
BG106481A (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumour agents
MY138352A (en) Benzothiazole derivatives
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
HU9202265D0 (en) Wall-mounted disc for joining sanitary equipments onto mounting wall
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
IT1250749B (it) Composti eterociclici ad attivita' a ii antagonista
ZA988527B (en) Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents.
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
TR199900732T2 (xx) PDE IV inhibe eden 2-siyanoiminoimidazol t�revleri.
SI1105105T1 (sl) Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole
MX9804426A (es) Derivados de imidazol fusionados como moduladores de la resistencia a los farmacos multiples.
GEP20084306B (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
IL127177A (en) ANTIPYSYCHOTIC 5-(1, 3, 4, 4a, 5, 9b-HEXAHYDRO-PYRIDO (3, 4-b) INDOL-2-YLALKYL) PYRIMIDIN-4-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL145645A0 (en) N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
IL138634A (en) Use of lasofoxifene for the prepartion of single dose medicament
HU9801792D0 (en) 4-aminopyrrole(3,2-d)pyrimidines as neuropeptide y receptor antagonists
BR0214780A (pt) Sal de ácido cìtrico de um composto terapêutico e composições farmacêuticas deste
NO20014889L (no) Fremgangsmåte for fremstilling av medisinske midler
HK1022420A1 (en) The use of homocysteine derivatives for the treatment of bacterial infections.
DE69917236D1 (de) Heterocyclische anthracyclinonderivate